Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005308 220002080 null null Curative (C) 2017-11-22 2017-11-24 Trial Unspecified Y N 220027886 TRIAL
220005309 220002081 1.58 81.5 Palliative (P) null 2017-01-24 CYTARABINE N N 220027892 CYTARABINE
220005310 220002081 null 80 Curative (C) 2017-04-15 2017-04-15 AML17 TRIAL N N 220027892 AML17 TRIAL
220005311 220002081 1.81 62.4 Curative (C) 2017-01-20 2017-01-20 AML17 TRIAL null N 220027892 AML17 TRIAL
220005312 220002081 1.83 82.4 Palliative (P) 2016-01-21 2016-01-22 Trial Unspecified 1 N 220027892 TRIAL
220005313 220002082 null 67.55 Disease modification (D) 2017-11-05 2017-11-05 Cytarabine low (10to20mg/m2) IV/SC N N 220027902 CYTARABINE
220005314 220002082 1.63 64.5 Disease modification (D) 2017-09-24 2017-09-25 Cytarabine Low Dose 2 N 220027902 CYTARABINE
220005315 220002082 null null Curative (C) 2016-02-27 2016-03-01 CYTARABINE N N 220027902 CYTARABINE
220005316 220002083 1.57 0 Palliative (P) 2015-03-01 2015-03-04 Cytarabine low (10to20mg/m2) IV/SC N N 220027906 CYTARABINE
220005317 220002084 null 80 Curative (C) null 2016-11-17 Trial Unspecified Y null 220027908 TRIAL
220005318 220011119 1.73 null Curative (C) 2013-10-01 2013-10-02 AML17 TRIAL 1 null 220027909 AML17 TRIAL
220005319 220011119 1.75 86.9 Palliative (P) 2017-08-28 2017-08-28 Cytarabine Low Dose 2 null 220027909 CYTARABINE
220005320 220011119 1.78 0 Palliative (P) 2014-12-17 2014-12-20 Cytarabine Low Dose N N 220027909 CYTARABINE
220005321 220002085 1.32 53 Not known (9) 2014-03-11 2014-03-11 Trial Unspecified Y N 220027921 TRIAL
220005322 220002085 1.6 null Curative (C) 2017-12-24 2017-12-24 Trial Unspecified 01 N 220027921 TRIAL
220005323 220002086 1.68 null Curative (C) 2015-10-21 2015-10-28 AML17 TRIAL Y N 220027927 AML17 TRIAL
220005324 220002086 1.83 106.1 Palliative (P) 2013-06-13 2013-06-21 Cytarabine low (10to20mg/m2) IV/SC N N 220027927 CYTARABINE
220005325 220002087 1.71 null Curative (C) 2015-08-01 2015-08-03 AML17 TRIAL Y null 220027929 AML17 TRIAL
220005326 220002087 null 64.5 Not known (9) null 2017-01-17 Cytarabine Low Dose 02 N 220027929 CYTARABINE
220005327 220002087 1.7 null Curative (C) 2016-08-18 2016-08-18 AML17 TRIAL 02 N 220027929 AML17 TRIAL
220005328 220002088 1.73 67.3 Curative (C) 2015-11-07 2015-11-09 Trial Unspecified Y N 220027937 TRIAL
220005329 220002089 null 88 Not known (9) 2015-04-10 2015-04-16 AML17 TRIAL N N 220027939 AML17 TRIAL
220005330 220002090 null 76 Disease modification (D) 2015-12-31 2015-12-31 AML17 TRIAL N null 220027940 AML17 TRIAL
220005331 220002090 null 83 Adjuvant (A) 2015-05-02 2015-05-02 AML17 TRIAL 01 N 220027940 AML17 TRIAL
220005332 220002091 1.67 null Curative (C) 2017-10-10 2017-10-10 Trial Unspecified 1 null 220027944 TRIAL
220005333 220002092 null null Palliative (P) 2013-10-06 2013-10-21 Cytarabine Low Dose null N 220027950 CYTARABINE
220005334 220002092 1.75 70.8 Curative (C) 2017-02-20 2017-02-20 AML17 TRIAL null null 220027950 AML17 TRIAL
220005335 220002092 0 null Palliative (P) 2013-01-24 2013-01-25 Cytarabine Low Dose 02 N 220027950 CYTARABINE
220005336 220002093 1.7 null Curative (C) 2017-06-26 2017-06-26 AML17 TRIAL Y N 220027955 AML17 TRIAL
220005337 220002093 1.58 94.4 null 2015-12-08 2015-12-15 LI-1 TRIAL 1 N 220027955 TRIAL
220005338 220002094 1.57 null Palliative (P) 2017-09-16 2017-09-23 CYTARABINE N N 220027959 CYTARABINE
220005339 220011126 null 59.6 Curative (C) 2016-10-07 2016-10-07 AML17 TRIAL 01 N 220027960 AML17 TRIAL
220005340 220002095 null 67.55 Palliative (P) 2015-03-14 2015-03-14 Cytarabine Low Dose N N 220027965 CYTARABINE
220005341 220011127 null 62.4 Curative (C) 2013-03-25 2013-03-25 AML17 TRIAL null null 220027970 AML17 TRIAL
220005342 220011127 1.82 93 Not known (9) 2015-08-18 2015-08-18 AML17 TRIAL N N 220027970 AML17 TRIAL
220005343 220002096 null 80.9 Curative (C) 2013-02-25 2013-02-25 Trial Unspecified Y N 220027972 TRIAL
220005344 220002097 null 91.2 Radical (R) 2015-01-03 2015-01-10 Trial Unspecified Y N 220027979 TRIAL
220005345 220002097 1.44 0 Palliative (P) 2016-03-19 2016-03-20 CYTARABINE 02 N 220027979 CYTARABINE
220005346 220002098 1.8 81.6 null 2013-09-17 2013-09-17 CYTARABINE N N 220027982 CYTARABINE
220005347 220011129 1.61 92 Curative (C) 2016-08-26 2016-09-06 LI-1 TRIAL Y N 220027984 TRIAL
220005348 220011129 null null Curative (C) 2014-11-25 2014-11-26 Cytarabine Low Dose N N 220027984 CYTARABINE
220005349 220002099 1.71 null Palliative (P) 2015-07-08 2015-07-08 Cytarabine Low Dose N N 220027986 CYTARABINE
220005350 220002099 1.9 83.5 Disease modification (D) 2016-03-12 2016-03-13 Cytarabine Low Dose 02 null 220027986 CYTARABINE
220005351 220015954 1.63 null Curative (C) 2017-12-23 2017-12-24 AML17 TRIAL 1 N 220027990 AML17 TRIAL
220005352 220015954 1.74 80.1 Not known (9) 2013-01-13 2013-01-13 AML17 TRIAL null null 220027990 AML17 TRIAL
220005353 220015954 1.79 50 null 2017-07-07 2017-07-09 LI-1 TRIAL Y null 220027990 TRIAL
220005354 220015954 1.63 94.2 null 2017-05-11 2017-05-11 AML17 TRIAL 1 N 220027990 AML17 TRIAL
220005355 220015954 1.59 48.8 Not known (9) null 2015-04-11 Trial Unspecified N N 220027990 TRIAL
220005356 220021991 1.83 91.5 Disease modification (D) 2017-08-17 2017-08-17 AML17 TRIAL Y N 220028014 AML17 TRIAL
220005357 220002100 0 75.4 Curative (C) 2017-08-03 2017-08-03 Cytarabine low (10to20mg/m2) IV/SC N N 220028015 CYTARABINE